Pricing Log in Create free account

Immuneering Corporation (IMRX) vs Vanda Pharmaceuticals Inc. (VNDA)

Immuneering Corporation and Vanda Pharmaceuticals Inc. are both Biotechnology companies. Immuneering Corporation and Vanda Pharmaceuticals Inc. are of similar size ($238.3M and $231.0M). Vanda Pharmaceuticals Inc. grew revenue faster over the last twelve months: 8.11% against −84.8%. Immuneering Corporation has the higher net margin (0.00% vs −119.9%) and the lower return on invested capital (−198.4% vs −180.2%). Across the 17 metrics below, Immuneering Corporation leads on 10 and Vanda Pharmaceuticals Inc. on 7.

Valuation

Metric IMRX VNDA Biotechnology median
P/E n/m n/m 10.60
P/S 751.21 1.01 9.40
P/B 1.41 1.16 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 292.52 0.40 9.02
Earnings yield (28.10%) (121.02%) (32.88%)
Free cash flow yield (25.95%) (64.93%) (23.13%)

Profitability

Metric IMRX VNDA Biotechnology median
Gross margin 0.00% 93.59% 68.51%
Operating margin 0.00% (77.59%) 0.00%
Net margin 0.00% (119.87%) 0.00%
Free cash flow margin 0.00% (65.41%) 0.00%
Return on equity (33.53%) (82.55%) (51.96%)
Return on assets (31.40%) (55.89%) (46.06%)
Return on invested capital (198.38%) (180.19%) 0.00%

Growth

Metric IMRX VNDA Biotechnology median
Revenue growth (TTM) (84.76%) 8.11% 6.76%
EPS growth (last fiscal year) 37.75% (1,033.33%) 29.88%
Revenue growth, 5-year CAGR — (2.73%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMRX VNDA Biotechnology median
Debt to equity 0.00 0.01 0.00
Current ratio 13.97 1.54 4.97
Net debt to EBITDA 2.94 1.84 1.01

Dividend

Metric IMRX VNDA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IMRX VNDA Biotechnology median
Market cap 238.33m 230.99m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack